AllantoinvsLactic Acid

Allantoin (5-ureidohydantoin) stimulates cell proliferation and tissue regeneration by promoting fibroblast activity, keratinocyte proliferation, and extracellular matrix synthesis including collagen and glycosaminoglycans. It acts as a mild keratolytic by promoting the natural desquamation process—loosening corneocyte adhesion and facilitating shedding—without the irritation, pH disruption, or barrier compromise associated with alpha- or beta-hydroxy acids. Allantoin has anti-inflammatory properties through modulation of prostaglandin synthesis (inhibiting COX-2 and reducing PGE2) and may downregulate pro-inflammatory cytokines. Its moisturizing effect comes from increasing the water-binding capacity of the extracellular matrix and stratum corneum; it is highly soluble and forms hydrogen bonds with water. Allantoin also promotes wound epithelialization. Its safety profile—non-irritating, non-sensitizing, non-comedogenic—makes it suitable for compromised skin, post-procedure care, and infant formulations.

Lactic acid (90 Da, larger than glycolic acid) exfoliates via the standard AHA mechanism: chelating calcium at corneodesmosomes and promoting desquamation through protease activation. Unlike glycolic acid, lactic acid is a natural component of the skin's natural moisturizing factor (NMF) and functions as a humectant, drawing water into the stratum corneum through hygroscopic binding. It inhibits tyrosinase enzyme activity in melanocytes, providing mild brightening. At higher concentrations (10%+), lactic acid upregulates serine palmitoyltransferase and glucosylceramide synthase in keratinocytes, stimulating ceramide synthesis and improving barrier lipid composition. It also enhances filaggrin proteolysis to NMF components. This dual action—exfoliation plus barrier support—makes it the most moisturizing AHA and clinically useful for dry, sensitive, or barrier-compromised skin.